Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
Khunti et al., The Lancet Diabetes & Endocrinology, doi:10.1016/S2213-8587(21)00050-4
https://c19early.org/khunti.html